CLINICAL_TRIALS
research
· 2025-11-24
Clinical Trial Update: Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD) [NA]
Summary
The ACT-AD study is evaluating cerebellar transcranial magnetic stimulation as a treatment for Alzheimer's disease. It is currently recruiting and sponsored by …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Xijing Hospital | Conditions: Alzheimer Disease, Transcranial Magnetic Stimulation | NA | Status: RECRUITING